K18 FutureIQ Serum 90ml

Brand:K18

K18 FutureIQ Hair Serum 90ml

Price $175.96

Lowest available price  RY.com.au, Look Fantastic  In stock

RY.com.au's price unchanged since 19 Nov

Unchanged since we started tracking

Price updated yesterday Price history

Buy at RY.com.au · $175.96

We may earn a commission at no cost to you. How it works

Price history

Tracking since 2 days ago

The price hasn't changed since we started tracking it. We'll show its history once it does.

Available at 2 stores

Stores may pay us a commission when you buy; it doesn't affect the order or your price. Learn more

Prices at each store
RetailerPriceAvailabilityUpdated
$175.96In stockYesterday
Cheapest $175.96In stockYesterday

About this product

Brand
K18
Category
Health & Beauty > Personal Care > Hair Care > Hair Treatments > Hair Serums

Specifications

Size
90 ml

K18's first-ever hair longevity serum, designed to tackle premature hair and scalp ageing where it begins.

At its heart is MultiVital™ technology, a multi-pathway system combining biomimetic peptides, a root anchoring complex and advanced antioxidants. Working together, they help slow the breakdown of the root proteins that keep hair anchored in place, support the natural signalling behind melanin production, and boost the follicle's defences against oxidative stress.

Used once nightly, the result is less shedding, fewer visible greys and a stronger, healthier scalp barrier.

  • Up to 19,000 more hairs
  • 100% showed reduced hair fall
  • 70% showed fewer greys after 3 months
  • 100% showed improved scalp barrier function

Month 1 — Renewal

  • 100% showed reduced hair fall
  • 82% agree it did not add oiliness to hair
  • 95% agree it did not increase scalp sensitivity

Month 2 — Momentum

  • Up to 10,000 more hairs for added fullness
  • 87% showed increased density
  • 100% showed improved scalp barrier

Month 3 — Visible Transformation

  • Up to 19,000 more hairs for added fullness
  • 70% showed fewer greys
  • 54% said their scalp felt revitalised

Results from a 12-week clinical study.